04/24/2024
11:15 PM | Acumen Pharmaceuticals (Filer)
| Form EFFECT | |
04/22/2024
3:33 PM | Acumen Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
3:30 PM | Acumen Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2024
3:31 PM | Acumen Pharmaceuticals (Filer)
| Form DEFA14A | |
03/27/2024
3:34 PM | Acumen Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/27/2024
3:34 PM | Acumen Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/26/2024
8:16 AM | Acumen Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
03/26/2024
6:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:05 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:32 AM | Acumen Pharmaceuticals (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/06/2024
8:02 AM | Acumen Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G | |
02/01/2024
4:01 PM | Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/01/2024
4:02 PM | Acumen Pharmaceuticals (Issuer)
Doherty James J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:16 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
3:22 PM | Acumen Pharmaceuticals (Subject)
MURRAY JAMES B JR (Filed by)
| Form SC 13G/A | |
01/19/2024
6:04 PM | Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:05 PM | Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:05 PM | Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:06 PM | Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
6:07 PM | Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:35 PM | Acumen Pharmaceuticals (Subject)
OConnell Daniel Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
3:36 PM | Acumen Pharmaceuticals (Subject)
Meisner Derek M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:27 PM | Acumen Pharmaceuticals (Subject)
Zuga Matt (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:28 PM | Acumen Pharmaceuticals (Subject)
Barton Russell (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
3:29 PM | Acumen Pharmaceuticals (Subject)
Siemers Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
7:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:33 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:20 PM | Acumen Pharmaceuticals (Issuer)
Zuga Matt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:21 PM | Acumen Pharmaceuticals (Issuer)
Siemers Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:22 PM | Acumen Pharmaceuticals (Issuer)
Meisner Derek M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:23 PM | Acumen Pharmaceuticals (Issuer)
Barton Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:18 PM | Acumen Pharmaceuticals (Issuer)
OConnell Daniel Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
6:45 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
6:20 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
5:31 PM | Acumen Pharmaceuticals (Issuer)
Ives Jeffrey L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
10:46 AM | Acumen Pharmaceuticals (Subject)
Ives Jeffrey L. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023
6:33 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
3:49 PM | Acumen Pharmaceuticals (Filer)
| Form 424B5 | |
07/17/2023
3:44 PM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2023
5:06 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2023
3:21 PM | Acumen Pharmaceuticals (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The 2024 Gold Rush: Unleashing Market Potential (Ad) Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. |
06/07/2023
4:40 PM | Acumen Pharmaceuticals (Issuer)
Drapkin Kimberlee C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:42 PM | Acumen Pharmaceuticals (Issuer)
Fountain Nathan B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:43 PM | Acumen Pharmaceuticals (Issuer)
Ives Jeffrey L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:43 PM | Acumen Pharmaceuticals (Issuer)
Porter Derrell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:44 PM | Acumen Pharmaceuticals (Issuer)
Stoppel Laura (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
4:45 PM | Acumen Pharmaceuticals (Issuer)
Stalfort John A III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2023
6:08 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
